TOKAI PHARMACEUTICALS INC - COM (TKAI)

CUSIP: 88907J107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
5,270,581
Share change
-1,461,483
Total reported value
$45,957,153
Price per share
$8.72
Number of holders
53
Value change
-$13,892,250
Number of buys
28
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 88907J107?
CUSIP 88907J107 identifies TKAI - TOKAI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TOKAI PHARMACEUTICALS INC - COM (TKAI) as of Q4 2015

As of 31 Dec 2015, TOKAI PHARMACEUTICALS INC - COM (TKAI) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,270,581 shares. The largest 10 holders included Bank of New York Mellon Corp, FMR LLC, BlackRock Fund Advisors, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, Novo A/S, AMERIPRISE FINANCIAL INC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, and BlackRock Institutional Trust Company, N.A.. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.